MedPath

A Prospective Observational Study on the Efficacy of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Chronic Heart Failure

Not Applicable
Recruiting
Conditions
Heart failure
Registration Number
JPRN-UMIN000045569
Lead Sponsor
Hokkaido University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Those who are not tolerant of ARNI (2) Those who are judged by the principal investigator to be inappropriate as research subjects.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in biomarkers before and after the introduction of ARNI
Secondary Outcome Measures
NameTimeMethod
(1) Relationship between changes in biomarkers and prognosis (2) Comparison of the clinical course of information obtained from medical record data. (3) Correlation with various examinations, symptoms, etc. obtained from the medical record base (4) Examination of factors involved in the effect of treatment obtained from the medical record base
© Copyright 2025. All Rights Reserved by MedPath